ArticleAnnals of medicine2025
Association of serological biomarkers with muscle strength and function in sarcopenia: a cross-sectional study.
Article in Annals of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis study investigated the relationship between serological biomarkers and sarcopenia, with a focus on muscle strength and physical function. MATERIALS AND
methodsA cross-sectional exploratory study was conducted involving 77 patients admitted to the General Practice Department, Longyan First Affiliated Hospital of Fujian Medical University from April 2023 to April 2024. Patients were sorted into the sarcopenia group (
resultsPatients with sarcopenia had significantly lower fasting insulin, folate, and hemoglobin levels, as well as reduced calf circumference, handgrip strength, and 6-m walking speed (
conclusionFolate level is independently associated with sarcopenia. Serological biomarkers, including UA, 1,25-Hydroxy vitamin D3, albumin, hemoglobin, and GGT, may serve as indicators of muscle functionand potential targets for early intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.